Oriza-backed Chinese Biotechnology Firm Ascentage Pharma Files For Hong Kong IPO

This Data Is Locked!

This area is available only to Subscribers.

Suzhou-based biopharmaceutical company Ascentage Pharma Group International has filed for an initial public offering in Hong Kong, according to its IPO prospectus. Following Hangzhou-based Ascletis... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?